Nouscom Company

Nouscom are a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
Industry: Viral Vectors
Headquarters: Basel, Basel-Stadt, Switzerland
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 5
Total Funding: 62340365
Estimated Revenue: Less than $1M
Last Funding Date: 2017-11-06
Last Funding Type: Series B

Visit Website
Register and Claim Ownership